Generics 10

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Iron hydroxide polymaltose manufacturers

10 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

10 products found

iron hydroxide polymaltose + folic acid

Tablets 100 mg + 350 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18722
This pharmaceutical manufacturer boasts decades of experience in the industry, providing a broad range of affordable finished formulations, including prescription drugs, OTC medications, and supplements. They offer turnkey manufacturing, technology transfer, contract development and manufacturing services, as well as co-development and co-marketing options. Key therapy areas include chronic and acute therapies, OTCs, and complex formulations. Dosage forms include tablets, capsules, syrups, powders, liquids, injections, and ointments. They have obtained GMP approvals from regulatory bodies in the EU, North America, and other regions, demonstrating their commitment to quality and compliance. The company's global presence extends to key regions like North America, Asia, and Africa, solidifying their position as a trusted partner in the pharmaceutical industry.

Manufacturer usually replies in 13 days

iron hydroxide polymaltose + folic acid

Tablets, film coated 100 mg + 350 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
Manufacturer #22627

This CTD dossier owner and manufacturer was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

Manufacturer usually replies in 30 days

iron hydroxide polymaltose + folic acid

Capsules 100 mg + 550 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17691
This company is a global pharmaceutical manufacturer with a focus on developing and manufacturing a wide range of high-quality injectable medicines. They provide a diverse product portfolio encompassing tablets, capsules, injectables, dry syrups, liquids, drops, creams, and inhalers. The company operates in the European Union and North America, demonstrating compliance with international quality standards. Their dedication to innovation and customer satisfaction is reflected in their in-house design department and their commitment to providing cost-effective solutions and reliable supply chains. Key therapy areas include cardiology, oncology, and infectious diseases, though other areas are also likely addressed. The company has a history of providing custom manufacturing solutions and research and development services, highlighting their expertise in the industry.

Manufacturer usually replies in 32 days

Want to see all 10 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Iron polymaltose is a pharmaceutical substance used to treat iron deficiency or iron-deficiency anemia. Suppliers market the medication as 100mg iron polymaltose tablets (either film-coated or chewable) as well as iron polymaltose 10mg/ml oral solutions and 50mg/ml drops. The drug was first introduced into the market in 1978, and has since then become approved in and supplied to over 80 countries. The largest manufacturers and suppliers of iron polymaltose are Vifor and Sanofi-Aventis. And it is available as both generic and trade name medications. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Retail prices per 30 tablets of iron polymaltose as well as for a 100ml of iron polymaltose 10mg/ml syrup fall into a range of approximately 6-8 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.